Historic medical cannabis deal set to create jobs for Nottingham firm

A multimillion-pound partnership between Nottingham medical cannabis provider, Releaf, and the leading domestic producer of medical cannabis, has become the UK medical cannabis sector’s largest to date.

The deal will see Surrey-based Glass Pharms provide Releaf with 145kg of medical grade cannabis.

Releaf is the largest medical cannabis provider in the UK. The company’s patient base is expected to exceed the current size of the entire UK sector, which is estimated at 45,000 patients, in the next 12 months.

Currently, Releaf’s doctors are seeing more than 100 patients per day.

The firm says the partnership with Glass Pharms ensures a reliable and consistent UK-based supply chain of high-quality medical cannabis, which address the prescription reliability issues that have plagued the industry and hindered the maturation of many other businesses.

Tim Kirby, CEO at Releaf, said: “This partnership with Glass Pharms marks a significant milestone not just for Releaf but for the entire UK medical cannabis industry. It’s the largest deal in UK history and underlines the growing recognition of medical cannabis as a legitimate healthcare solution. By securing a high-quality domestic supply of this medication, we’re not just meeting demand—we’re setting a new standard for reliability and patient care in this sector.”

Glass Pharms brings cutting-edge AI and robotic automation to the cultivation of medical cannabis, ensuring product quality and consistency.

Meanwhile, Releaf’s proprietary health tech platform, which enables seamless patient care from diagnosis to medication access, has been a key factor in its ability to manage rapid growth.

Releaf’s expansion is expected to create jobs and develop new skills within the UK’s medical cannabis industry.